Meagan E Crowther

Dr. Meagan E Crowther

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2025 in Sleep Medicine Reviews
Verified
Journal Article
Open access
SLShane Landry
Shane Landry
EHElly M.P. Howell
Elly M.P. Howell
MCMeagan E Crowther
Meagan E Crowther
DTDaniel J. Tan
Daniel J. Tan
CBCaroline Beatty
Caroline Beatty
BEBradley Edwards
Bradley Edwards
Contrary to the view that a lower arousal threshold causes greater susceptibility to obstructive sleep apnoea (OSA), the arousal threshold has been shown to decrease following treatment with continuous positive airway pressure (CPAP) therapy. This effect has not been consistently demonstrated with other non-CPAP therapies. We systematically reviewed all randomised and non-randomised trials (of non-hypnotic therapy) for OSA, in which respiratory arousal threshold was quantified both on- and off-treatment. Random effects meta-analysis models were used for all meta-analyses. Our analysis demonstrates that OSA treatment is associated with a significant reduction in the respiratory arousal threshold (standardised mean difference = -0.36 [CI95 % -0.49, -0.22], p < 0.001), however, this effect was highly heterogenous (I2 = 67.6 %). Greater reductions in the arousal threshold are observed in studies with highly efficacious treatment as quantified by larger absolute reductions in the apnoea-hypopnea index (AHI, r2 = 0.26, p = 0.002) and increases in SpO2 nadir (r2 = 0.74, p < 0.001). These data provide support for the notion that reductions in the respiratory arousal threshold occur as an indirect consequence of treatment. Importantly, reductions in the respiratory arousal threshold should be an expected finding in trials in which a treatment has successfully reduced OSA severity.